Evaluation of the Association Between Depression and Glycemic Control in People With Type 1 Diabetes
Study Details
Study Description
Brief Summary
Single-center prospective observational pilot study
The aim of the study is to evaluate the potential association between the percentage of time spent in the optimal glycemia range and the score obtained in the questionnaires used to screen for depression.
The study involves only one visit for each participant. Each participant will be asked to sign the informed consent to the study and, during the visit, the following information will be acquired: parameters, history of diabetes, concomitant diseases and medications, and CGM metrics.
The participant will be administered the following questionnaires for the evaluation of depression, patient-reported outcome measure (PROMs) and treatment satisfaction:
-
Patient Health Questionnaire (PHQ-9)
-
Center of Epidemiological Studies-Depression Scale (CES-D)
-
Diabetes Treatment Satisfaction Questionnaire (DTSQ)
-
Well-Being Index (WHO-5)
-
Problem Areas In Diabetes (PAID-5)
-
European Quality of Life, Five Dimension, Five Level (EQ5D5L)
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- Relationship between time in range a depression questionnaire CES-D [14 days]
Evaluation of the relationship between time in optimal glycemic range (70-180 mg/dl) and scores at depression questionnaire
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Informed consent before any activity foreseen by the protocol
-
Age > 18 years
-
Subjects with type 1 diabetes mellitus, both on multiple daily injection and with insulin pump, using glucose monitoring systems, both flash glucose monitoring and continuous glucose monitoring
Exclusion criteria:
-
Type 2 diabetes mellitus or other forms of diabetes, such as steroid-induced or secondary to pancreatectomy, pancreatitis, or secondary to endocrinological disorders
-
Previous diagnosis of major depression, bipolar disorder, psychotic disorder, eating disorder (anorexia nervosa, bulimia nervosa, binge eating disorder)
-
Chronic treatment with corticosteroids
-
BMI <19kg/m2
-
Known history of substance or alcohol abuse
-
Patients who have recently been admitted to the psychiatry ward or are being treated with psycho-drugs
-
Conditions that do not allow participation in the activities envisaged by the protocol
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Università Cattolica del Sacro Cuore | Roma | Italy | 00168 |
Sponsors and Collaborators
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 5733